C

Catalyst Biosciences Inc
F:HGF2

Watchlist Manager
Catalyst Biosciences Inc
F:HGF2
Watchlist
Price: 7.404 EUR 1 377.84%
Market Cap: 279.6m EUR

Wall Street
Price Targets

HGF2 Price Targets Summary
Catalyst Biosciences Inc

There are no price targets for HGF2.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Catalyst Biosciences Inc Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
545% Upside
ANAB
AnaptysBio Inc
81% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
55% Downside
005690
Pharmicell Co Ltd
56% Upside
VIR
Vir Biotechnology Inc
624% Upside
4893
Noile-Immune Biotech Inc
175% Upside
ACAD
ACADIA Pharmaceuticals Inc
14% Upside
688105
Nanjing Vazyme Biotech Co Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Catalyst Biosciences Inc

For the last 1 year the compound annual growth rate for Catalyst Biosciences Inc's revenue is -89%.

-89%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Catalyst Biosciences Inc

Operating Income forecast
is not available for
Catalyst Biosciences Inc

Net Income
Forecast

Net Income Estimate
Catalyst Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HGF2's stock price target?
Not Available

HGF2 doesn't have any price targets made by Wall Street professionals.

Back to Top